ArticleEcho research and practice2026
Strain characterization of multi-chamber cardiac dysfunction and associated prognosis in patients undergoing TAVR for severe AS.
Article in Echo research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR), myocardial dysfunction may extend beyond the left ventricle and remain underrecognized by conventional severity classification paradigms. Strain echocardiography allows early detection of subclinical dysfunction across cardiac chambers, potentially enhancing prognostic stratification.
methodsWe retrospectively analysed 234 patients with severe AS undergoing TAVR who had echocardiograms suitable for strain analysis. Left ventricular (LV), left atrial (LA), and right ventricular (RV) strain values were quantified pre- and post-TAVR. Chamber dysfunction was defined using consensus strain thresholds, and multichamber impairment (MCI) was defined by dysfunction in two or more chambers. A modified damage staging system incorporating strain data was compared to an established model. The association between chamber impairment and all-cause mortality was explored.
resultsStrain-defined chamber impairment was common, with 29% of patients exhibiting MCI. LA dysfunction was the most frequent isolated abnormality, accounting for 88% of single chamber impairment. Modest improvement was observed post-TAVR, predominantly in LV global longitudinal strain (+ 1.8 ± 3.5%, p < 0.01). MCI was associated with higher rates of atrial fibrillation, chronic kidney disease, and mitral/tricuspid regurgitation. At 12-month follow-up, patients with three-chamber impairment had significantly increased mortality risk (HR 6.84, 95% CI 1.77-26.4, p = 0.005). The modified staging system reclassified 27% of patients into higher risk categories but did not significantly improve predictive accuracy over the established model.
conclusionMultichamber dysfunction, particularly involving the LA, is prevalent in patients undergoing TAVR and confers a higher early mortality risk. While the addition of strain data improves damage detection, its incremental prognostic value over conventional models appears modest in this cohort. Larger studies are required to explore this further. Comprehensive strain imaging may nonetheless identify patients requiring closer surveillance and targeted post-TAVR therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.